TS
Taiji Sakamoto

Elite Scholar

633
Works
13,997
Citations
60
H-Index
Search Authors
Author Statistics
External Links
OpenAlex Profile ORCID Profile

Taiji Sakamoto

Also known as: Sakamoto, Taiji, T Sakamoto, T. Sakamoto, TAIJI SAKAMOTO, Taiji SAKAMOTO

633

Total Works

13,997

Citations

60

H-Index

316

i10-Index

Citation & Works Trend by Year
44 years active
Top Research Topics
Retinal Diseases and Treatments (440) Retinal and Macular Surgery (251) Ocular Diseases and Behçet’s Syndrome (189) Retinal Imaging and Analysis (136) Glaucoma and retinal disorders (109)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 Correction: Aflibercept 8 mg in neovascular age-related macular degeneration and diabetic macular oedema: Translating clinical trials into clinical practice Eye 0
2026 Assessing awareness toward genetic testing among patients with inherited retinal dystrophy in Japan Japanese Journal of Ophthalmology 0
2026 Quantification of vitreous VEGF-A121 and VEGF-A165 using an isoform-specific ELISA in proliferative diabetic retinopathy Graefe s Archive for Clinical and Experimental Ophthalmology 0
2026 Aflibercept 8 mg in neovascular age-related macular degeneration and diabetic macular oedema: Translating clinical trials into clinical practice Eye 0
2026 Plain language summary of publication of the 96-week results from the PHOTON study: intravitreal aflibercept 8 mg for diabetic macular edema Therapeutic Advances in Ophthalmology 0
2026 Aflibercept biosimilar use and real-world outcomes in various retinal diseases: the AURA Korea study Scientific Reports 0
2026 Who safeguards science? — The crisis of information overload and research quality Graefe s Archive for Clinical and Experimental Ophthalmology 0
2026 Real-world effectiveness and safety of ranibizumab biosimilar FYB-201 in Saudi Arabia (Ravegza) and Jordan (Uptera): a middle eastern extension of the FORCE study Eye 0
2026 Parapapillary choroidal dense pigmentation in young healthy eyes: a cross-sectional study International Journal of Retina and Vitreous 0
2026 Brolucizumab in the Treatment of Proliferative Diabetic Retinopathy JAMA Ophthalmology 1
2026 A NEW TECHNIQUE USING ULTRA-WIDEFIELD CAMERA FOR IMPROVED NEOVASCULARIZATION DETECTION IN DIABETIC RETINOPATHY Retina 0
2026 Reduced-fluence photodynamic therapy versus placebo for central serous chorioretinopathy (REPLAY trial): rationale and study protocol of a pivotal double-blind randomised controlled trial BMJ Open 0
2026 Real-world durability challenges with nAMD treatments and the potential promise of gene therapy Current Medical Research and Opinion 0
2026 Aflibercept 2 mg Biosimilar (aflibercept-ayyh, Pavblu): Experience of safety in clinical settings-APEX- safety study Eye 0
2026 Potential 20-Week Faricimab Dosing in Wet Age-Related Macular Degeneration Ophthalmology Retina 2

Data source: OpenAlex API